🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Perspective Therapeutics, Inc.

CATX Healthcare
$1.61 $-0.65 (-28.76%)
Market Cap: $183.78 M
Gurus Holding
3
Popularity Rank
#2761
% of Shares Held
0.09%
Net Activity (Q2 2026)
-$612,534.39

Guru Ownership Trend

Guru Analysis for Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics, Inc. (CATX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $169,431.57.

Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $612,534.39 net outflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Paul Tudor Jones reduced exposure by 46.7%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$206,015.61
Total Buy Value
New Buys 1
Additions 1
-$818,550
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
2
Net Buyers
2

FAQs for Perspective Therapeutics, Inc. (CATX)

Major holders include Renaissance Technologies (RenTech) ($201,644), Cliff Asness ($95,473), Paul Tudor Jones ($61,741). According to the latest reported data, 3 tracked investment managers collectively hold approximately 105,237 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $612,534.39, with 2 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited CATX. The total reported sell value was $818,550.

Yes, 1 managers opened new positions in CATX, and 1 increased their existing holdings. The total reported buy value was $206,015.61.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% New Buy 59,133 $201,644 Q2 2026
0.00% Add 4.8% 27,998 $95,473 Q2 2026
0.00% Reduce -46.7% 18,106 $61,741 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form